MRUS Merus N.V.

Merus BV is a clinical stage immuno-oncology company. It is engaged in developing bispecific antibody therapeutics.

$15.89  +0.36 (2.32%)
As of 11/25/2022 13:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  05/19/2016
Outstanding shares:  46,302,877
Average volume:  473,892
Market cap:   $719,083,680
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BZBY005
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy